ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
117 hedge funds and large institutions have $1.1B invested in Alder Biopharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 56 increasing their positions, 35 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less call options, than puts
Call options by funds: $7.66M | Put options by funds: $15.5M
54% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 28
Holders
117
Holding in Top 10
7
Calls
$7.66M
Puts
$15.5M
Top Buyers
| 1 | +$44.2M | |
| 2 | +$40.5M | |
| 3 | +$25.7M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$18.1M |
| 5 |
PA
Perceptive Advisors
New York
|
+$9.18M |
Top Sellers
| 1 | -$26.1M | |
| 2 | -$7.42M | |
| 3 | -$7.18M | |
| 4 |
HCM
Highbridge Capital Management
New York
|
-$7.15M |
| 5 |
NLVP
New Leaf Venture Partners
New York
|
-$6.19M |